alex rodriguez getty

A-Rod releases statement denying the Miami New Times report

36 Comments

Alex Rodriguez has issued a statement in response to the report in the Miami New Times today in which patient records were released suggesting that he used performance enhancing drugs as recently as 2012:

“The news report about a purported relationship between Alex Rodriguez and Anthony Bosch are not true. Alex Rodriguez was not Mr. Bosch’s patient, he was never treated by him and he was never advised by him. The purported documents referenced in the story — at least as they relate to Alex Rodriguez — are not legitimate.”

This is a clear attack on the patient records released as unreliable.  Earlier, Major League Baseball released its own statement:

“We are always extremely disappointed to learn of potential links between players and the use of performance-enhancing substances.  These developments, however, provide evidence of the comprehensive nature of our anti-drug efforts.  Through our Department of Investigations, we have been actively involved in the issues in South Florida.  It is also important to note that three of the players allegedly involved have already been disciplined under the Joint Drug Program.

“The recommendations of the Mitchell Report have once again played a critical role in Major League Baseball’s ongoing efforts against performance-enhancing drugs.  MLB implemented all of the recommendations made by Senator Mitchell in 2007, several of which emphasized the significance of installing proactive investigative services.

“The establishment of our Department of Investigations has represented a critical advance in these comprehensive efforts.  In the years since its formation, DOI’s work has proven pivotal to bringing to light information regarding the use of performance-enhancing substances.  Furthermore, DOI has built strong working relationships with federal and local law enforcement authorities.  These relationships are crucial because only law enforcement officials have the capacity to reach those outside the game who are involved in the distribution of illegal performance-enhancing drugs.

“Vigilance remains the key toward protecting the integrity of our game.  We have the best and most stringent drug testing policy in professional sports, we continue to work with our doctors and trainers to learn what they are seeing day-to-day and we educate our players about the game’s unbending zero-tolerance approach.  We remain fully committed to following all leads and seeking the appropriate outcomes for all those who use, purchase and are involved in the distribution of banned substances, which have no place in our game.

“We are in the midst of an active investigation and are gathering and reviewing information.  We will refrain from further comment until this process is complete.”

With this, we are left with a he-said, he-said.  It will take more investigation by Major League Baseball and the DEA in order to determine what the significance is of the patient records reported on in the Miami New Times is, if any.

Cubs, Jake Arrieta avoid arbitration at $10.7 million

Jake Arrieta
AP Photo/Mark J. Terrill
1 Comment

The Associated Press is reporting that the Cubs and starter Jake Arrieta have avoided arbitration, agreeing to a $10.7 million salary for the 2016 season. That marks the highest salary on a one-year deal for a pitcher with four years of service, the AP notes. Arrieta and the Cubs were set to go before an independent arbitrator but now can simply focus on the season ahead.

Arrieta, 29, is in his second of three years of arbitration eligibility. He had filed for $13 million while the Cubs countered at $7.5 million. The $5.5 million gap was the largest among players who did not come to terms with their respective teams by the January deadline. The $10.7 million salary is $450,000 above the midpoint between the two submitted figures.

Arrieta won the National League Cy Young Award for his performance this past season, narrowly edging out Zack Greinke, then with the Dodgers. Arrieta led the majors with 22 wins, four complete games, and three shutouts. With that, he compiled a 1.77 ERA and a 236/48 K/BB ratio across 229 innings.

Once a top prospect in the Orioles’ minor league system, Arrieta struggled in the majors but found immediate success with the Cubs in 2013 after the O’s traded him along with Pedro Strop in exchange for Steve Clevenger and Scott Feldman.

Giants sign Conor Gillaspie to a minor league deal

Los Angeles Angels third baseman Conor Gillaspie is unable to hold on to the ball after catching a grounder hit by Kansas City Royals' Lorenzo Cain in the fourth inning of a baseball game at Kauffman Stadium in Kansas City, Mo., Friday, Aug. 14, 2015. (AP Photo/Colin E. Braley)
AP Photo/Colin E. Braley
Leave a comment

Per Baseball America’s Matt Eddy, the Giants have signed infielder Conor Gillaspie to a minor league deal. Gillaspie was selected by the Giants in the supplemental round of the 2008 draft, then was traded to the White Sox in February 2013.

Gillaspie, 28, hit a meager .228/.269/.359 with four home runs and 24 RBI in 253 plate appearances between the White Sox and Angels during the 2015 season. Almost all of his playing time has come at third base but he can also play first base if needed.

The Giants, thin on depth, will allow Gillaspie to audition in spring training for a spot on the 25-man roster.

Joe Nathan plans to pitch in 2016

Detroit Tigers relief pitcher Joe Nathan throws against the Chicago White Sox in the ninth inning of a baseball game in Detroit Tuesday, Sept. 23, 2014. (AP Photo/Paul Sancya)
AP Photo/Paul Sancya
2 Comments

Jon Morosi of FOX Sports reports that free agent reliever Joe Nathan, recovering from Tommy John surgery, plans to pitch in 2016 according to his agent Dave Pepe. According to Pepe, Nathan’s workouts are “going well” and the right-hander is “definitely planning on playing this year.”

Nathan, 41, got the final out on Opening Day (April 6) against the Twins before going on the disabled list with a flexor strain in his right elbow, causing him to miss the next 161 games. He will likely be able to contribute out of the bullpen in late May or early June if he has no setbacks. On a minor league deal or incentive-laden major league deal, Nathan could make for a low-risk gamble.

Over a 15-season career that dates back to 1999 (he did not pitch in the majors in 2001 or 2010), Nathan has 377 saves with a 2.89 ERA and a 967/340 K/BB ratio over 917 innings.

The Rays are considering reliever Tyler Clippard

New York Mets pitcher Tyler Clippard throws during the eighth inning of Game 4 of the National League baseball championship series against the Chicago Cubs Wednesday, Oct. 21, 2015, in Chicago. (AP Photo/Nam Y. Huh)
AP Photo/Nam Y. Huh
Leave a comment

On Thursday, we learned that the Diamondbacks were still considering free agent reliever Tyler Clippard. You can add the Rays to the list as well, per Marc Topkin of the Tampa Bay Times.

The Rays traded lefty reliever Jake McGee to the Rockies in exchange for outfielder Corey Dickerson in late January, so Clippard would be able to slot right in behind closer Brad Boxberger. Clippard, 30, compiled a 2.92 ERA with 64 strikeouts and 31 walks over 71 innings in a season split between the Athletics and Mets. The strikeout rate was at its lowest since the right-hander become a full-time reliever in 2009, and his walk rate was at its highest since 2010, which may be a factor in his still being a free agent in February.